305 related articles for article (PubMed ID: 27417323)
1. Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine.
Rosano GMC; Vitale C; Volterrani M
Cardiovasc Drugs Ther; 2016 Aug; 30(4):393-398. PubMed ID: 27417323
[TBL] [Abstract][Full Text] [Related]
2. Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review.
Mody P; Sidhu MS; Brilakis ES; Sacco JD; Banerjee S; Boden WE
Cardiol Rev; 2016; 24(4):177-89. PubMed ID: 26274534
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report.
Yuriivna Osovska N; Vitaliivna Kuzminova N
Pol Merkur Lekarski; 2016 Dec; 41(246):287-292. PubMed ID: 28024133
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine and Ivabradine: two different modalities to act against ischemic heart disease.
Cacciapuoti F
Ther Adv Cardiovasc Dis; 2016 Apr; 10(2):98-102. PubMed ID: 26944071
[TBL] [Abstract][Full Text] [Related]
5. Ranolazine: A Contemporary Review.
Rayner-Hartley E; Sedlak T
J Am Heart Assoc; 2016 Mar; 5(3):e003196. PubMed ID: 26979079
[No Abstract] [Full Text] [Related]
6. New Anti-Anginal Drugs: Ranolazine.
Cavallino C; Facchini M; Veia A; Bacchni S; Rosso R; Rognoni A; Rametta F; Lupi A; Bongo AS
Cardiovasc Hematol Agents Med Chem; 2015; 13(1):14-20. PubMed ID: 25544118
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Angina: Where Are We?
Balla C; Pavasini R; Ferrari R
Cardiology; 2018; 140(1):52-67. PubMed ID: 29874661
[TBL] [Abstract][Full Text] [Related]
8. Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
Sendón JL; Lee S; Cheng ML; Ben-Yehuda O;
Eur J Prev Cardiol; 2012 Oct; 19(5):952-9. PubMed ID: 22689417
[TBL] [Abstract][Full Text] [Related]
9. Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization.
Secco GG; Parisi R; Mirabella F; Rognoni A; Lupi A; De Luca G; Marino PN; Fattori R; Cremonesi A; Castriota F
Cardiovasc Hematol Agents Med Chem; 2015; 13(1):21-4. PubMed ID: 25544117
[TBL] [Abstract][Full Text] [Related]
10. [Triple antianginal combinations in the treatment of elderly and senile patients with stable angina].
Kanorskii SG; Smolenskaya NV
Ter Arkh; 2016; 88(12):33-40. PubMed ID: 28139557
[TBL] [Abstract][Full Text] [Related]
11. Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis.
Belsey J; Savelieva I; Mugelli A; Camm AJ
Eur J Prev Cardiol; 2015 Jul; 22(7):837-48. PubMed ID: 24776376
[TBL] [Abstract][Full Text] [Related]
12. Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence.
Ambrosio G; Tamargo J; Grant PJ
Diab Vasc Dis Res; 2016 Mar; 13(2):98-112. PubMed ID: 26873904
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
Page RL; Ghushchyan V; Read RA; Hartsfield CL; Koch BR; Nair KV
Am J Cardiol; 2015 Nov; 116(9):1321-8. PubMed ID: 26358510
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.
Bress AP; Dodson JA; King JB; Sauer BC; Reese T; Crook J; Radwanski P; Knippenberg K; Greene T; Nelson RE; Munger MA; Weintraub WS; LaFleur J
Am J Cardiol; 2018 Dec; 122(11):1809-1816. PubMed ID: 30292334
[TBL] [Abstract][Full Text] [Related]
15. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
16. Ranolazine: effects on ischemic heart.
Rognoni A; Barbieri L; Cavallino C; Bacchini S; Veia A; Degiovanni A; Rametta F; Nardi F; Lazzero M; Lupi A; Bongo AS
Recent Pat Cardiovasc Drug Discov; 2013 Dec; 8(3):197-203. PubMed ID: 23961914
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine reduces angina frequency and severity and improves quality of life: Observational study in patients with chronic angina under ranolazine treatment in Greece (OSCAR-GR).
Alexopoulos D; Kochiadakis G; Afthonidis D; Barbetseas J; Kelembekoglou P; Limberi S; Spanos A; Triantafyllidis G
Int J Cardiol; 2016 Feb; 205():111-116. PubMed ID: 26730841
[TBL] [Abstract][Full Text] [Related]
18. Stable angina pectoris: the medical management of symptomatic myocardial ischemia.
Parker JD; Parker JO
Can J Cardiol; 2012; 28(2 Suppl):S70-80. PubMed ID: 22424287
[TBL] [Abstract][Full Text] [Related]
19. Ranolazine: Drug overview and possible role in primary microvascular angina management.
Cattaneo M; Porretta AP; Gallino A
Int J Cardiol; 2015 Feb; 181():376-81. PubMed ID: 25555283
[TBL] [Abstract][Full Text] [Related]
20. Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
Coleman CI; Freemantle N; Kohn CG
BMJ Open; 2015 Nov; 5(11):e008861. PubMed ID: 26546142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
